Literature DB >> 29959462

Symptomatic periprocedural intracranial hemorrhage unrelated to coil embolization in 1287 patients with intracranial aneurysms.

Haowen Xu1, Li Wang2, Sheng Guan1, Dongdong Li1, Tao Quan3.   

Abstract

PURPOSE: Periprocedural symptomatic intracranial hemorrhage (sICH) unrelated to coil embolization of intracranial aneurysm has been rarely reported. The incidence and characteristics of this complication remain unclear. This study was designed to elucidate the incidence and characteristics of periprocedural sICH unrelated to coiling of intracranial aneurysm, and to explore the possible mechanisms underlying this complication.
METHODS: Included in this retrospective study were 1287 patients with 1394 aneurysms who were treated with coil embolization (476 patients with stent assistance and 811 patients without stents) between May 2008 and August 2017. All procedure-unrelated sICHs that occurred within 30 days after coiling were selected. The technical details of the procedure, clinical characteristics, and medical therapy were recorded.
RESULTS: A total of 6 patients developed periprocedural sICH unrelated to coil embolization. All these six patients underwent stent-assisted coiling (SAC). Therefore, there was a 1.3% (6/476) procedure-unrelated sICH rate of SAC and 0% (0/811) in patients underwent coiling without stent during the periprocedural period (P = 0.005, RR 0.987; 95% CI, 0.977-0.997). These phenomena occurred more often in patients who received SAC for ruptured aneurysms vs patients underwent this technique for unruptured aneurysms (2.0 vs 0.7%, P = 0.390, RR 2.896; 95% CI, 0.525-15.968). All these phenomena occurred within 7 days after coiling, and resulted in one mortality, one unfavorable outcome (mRS Score 3), and other four favorable outcomes (mRS Scores 0-2) at 90 days after procedure.
CONCLUSION: Our findings suggest that the procedure-unrelated sICH, though less frequent, may exist following stent-assisted coiling of intracranial aneurysm during the periprocedural period. Extra caution may be warranted in patients who were treated with SAC for ruptured aneurysms.

Entities:  

Keywords:  Coil embolization; Intracranial aneurysm; Intracranial hemorrhage; Periprocedural period

Mesh:

Year:  2018        PMID: 29959462     DOI: 10.1007/s00234-018-2049-6

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  25 in total

1.  A multicenter study of 705 ruptured intracranial aneurysms treated with Guglielmi detachable coils.

Authors:  Sophie Gallas; Anne Pasco; Jean-Philippe Cottier; Jean Gabrillargues; Jacques Drouineau; Christophe Cognard; Denis Herbreteau
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.

Authors:  C Goh; L Churilov; P Mitchell; R Dowling; B Yan
Journal:  AJNR Am J Neuroradiol       Date:  2012-12-28       Impact factor: 3.825

Review 3.  Aneurysmal rupture during coiling: low incidence and good outcomes at a single large volume center.

Authors:  Jonathan L Brisman; Yasunari Niimi; Joon K Song; Alejandro Berenstein
Journal:  Neurosurgery       Date:  2005-12       Impact factor: 4.654

4.  Endovascular treatment of unruptured intracranial aneurysms: occurrence of thromboembolic events.

Authors:  Iris Quasar Grunwald; Panagiotis Papanagiotou; Maria Politi; Tobias Struffert; Christian Roth; Wolfgang Reith
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

5.  Rupture of intracranial aneurysms during treatment with Guglielmi detachable coils: incidence, outcome, and risk factors.

Authors:  M Sluzewski; J A Bosch; W J van Rooij; P C Nijssen; D Wijnalda
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

Authors:  J He; P K Whelton; B Vu; M J Klag
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

8.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

9.  Stent-assisted coil embolization of ruptured wide-necked aneurysms in the acute period: incidence of and risk factors for periprocedural complications.

Authors:  Joonho Chung; Yong Cheol Lim; Sang Hyun Suh; Yu Shik Shim; Yong Bae Kim; Jin-Yang Joo; Bum-Soo Kim; Yong Sam Shin
Journal:  J Neurosurg       Date:  2014-05-16       Impact factor: 5.115

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.